Haleon (HLN) Inventory (2021 - 2026)

Haleon's (HLN) quarterly Inventory came in at $1.4 billion in Q2 2026, up 4.63% on a QoQ basis from $1.4 billion in Q4 2025.

Haleon (HLN) Inventory (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Inventory data on file, last reported at $1.4 billion in Q2 2026.

Quarterly Inventory changed N/A year-over-year to $1.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.4 billion (changed N/A YoY) and the FY2025 annual result came in at $1.4 billion, down 10.37% from the prior year.
Inventory advanced to $1.4 billion in Q2 2026, from $1.4 billion in the prior quarter.
In the past five years, Inventory ranged from a high of $1.9 billion in Q2 2023 to a low of $1.4 billion in Q4 2025.
A 5-year average of $1.6 billion and a median of $1.6 billion in 2022 frame the typical range for Inventory.
Annual changes were most pronounced in 2023 — Inventory rose 29.81% — and 2024, when it slipped 12.6%.
Tracing HLN's Inventory over 5 years: stood at $1.6 billion in 2022, then gained by 10.53% to $1.7 billion in 2023, then decreased by 12.6% to $1.5 billion in 2024, then retreated by 10.09% to $1.4 billion in 2025, then rose by 4.63% to $1.4 billion in 2026.
The last three Inventory figures came in at $1.4 billion (Q2 2026), $1.4 billion (Q4 2025), and $1.5 billion (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-	1.44 Bn
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn	3.22 Bn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn	2.57 Bn
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn	9.08 Bn
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn	193.80 Mn
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn	3.93 Bn
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn	104.20 Mn
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn	1.77 Bn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-	816.00 Mn
10	Alkermes	8.20 Bn	7.55 Bn	397.90 Mn	298.96 Mn

Download Data